SynAct Pharma AB announced the appointments of Patrik Renblad as Vice President Finance and Lise Agersted as Director of Operational R&D. Mr. Renblad will be responsible for the finance function reporting to the CFO. Mrs. Agersted will report to the CSO. Both starts immediately. Mr. Renblad joins SynAct after a decade in various financial roles at LEO Pharma A/S, where he was most recently Finance Director, R&D, leading the R&D Business Finance Organization and was a member of the LEO Pharma Finance and R&D Leadership teams. Prior to LEO Pharma, Mr. Renblad worked nine years at AstraZeneca R&D in Lund, Sweden. Mrs. Agersted starts at SynAct after three years as an independent consultant for biotech and technology startups. Prior to this, Mrs. Agersted worked at Novo Nordisk for 8 years and held both scientific and project management roles, recently as Senior CMC Project Management.